Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Tapan M. Kadia, MD, Hongbing Ma, MD PhD, Ke Zeng, MD PhD, Mitsutaka Nishimoto, MD PhD, Mi-Ae Lyu, PhD, Meixian Huang, Musa Yilmaz, MD, Courtney D. DiNardo, MDMSc, Ghayas C. Issa, MD, Simrit Parmar, MBBS, Swami P. Iyer, MD, Parameswaran Hari, MBBS, MD, Naval G. Daver, MD, Elias Jabbour, MD, Gautam M. Borthakur, MD, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 1221.

DOI: https://doi.org/10.1182/blood-2019-127702

Published: 2019

Journal Articles

Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial

Ke Zeng, MD PhD, Hongbing Ma, MD PhD, Uday Popat, MD, Yago Nieto, MD PhD, Stefan O. Ciurea, MD, Amanda L. Olson, MD, Mi-Ae Lyu, PhD, Meixian Huang, Mitsutaka Nishimoto, MD PhD, Muzaffar H. Qazilbash, MD, Jennifer D Ramos, RN, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Simrit Parmar, MBBS, Borje S Andersson, MD PhD

Blood (2019) 134 (Supplement_1): 4547.

DOI: https://doi.org/10.1182/blood-2019-127726

Published: 2019

Journal Articles

Dysregulation of Follistatin Promotes Leukemogenesis in Acute Myeloid Leukemia

Alex Bai-Liang He, PhD, Nelson Ka Lam Ng, BA, Chae Yin Cher, Alan WL To, Chunxiao Zhang, Stephen SY Lam, Anskar Leung, MD PhD

Blood (2017) 130 (Supplement 1): 4982.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.4982.4982

Published: 2017

Journal Articles

Transcriptomal Evidence for Dysregulation of Angiogenic Factors and Inflammatory Markers after Allogeneic Hematopoietic Cell Transplantation

Laura F. Newell, MD, Kristina Vartanian, Christina A Harrington, PhD, Shernan G. Holtan, MD

Blood (2017) 130 (Supplement 1): 3259.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3259.3259

Published: 2017

Journal Articles

Follistatin and Endoglin: Potential Biomarkers of Endothelial Damage and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0402

Laura F. Newell, MD, Todd E. DeFor, MS, Corey S. Cutler, MD MPH, Michael R. Verneris, MD, Bruce R. Blazar, MD, Joseph H. Antin, MD, Alan Howard, PhD, Juan Wu, Margaret L. MacMillan, MD, Angela Panoskaltsis-Mortari, PhD, Daniel J. Weisdorf, MD, Shernan G. Holtan, MD

Blood (2016) 128 (22): 63.

DOI: https://doi.org/10.1182/blood.V128.22.63.63

Published: 2016

Journal Articles

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

Shernan G. Holtan, MD, Michael R. Verneris, MD, Kirk R. Schultz, MD, Laura Newell, MD, Gabrielle Meyers, MD, Fiona C. He, MD, Todd E. DeFor, MS, Margaret L. MacMillan, MD, Sarah A. Cooley, MD MS, Angela Panoskaltsis-Mortari, PhD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 2489.

DOI: https://doi.org/10.1182/blood.V124.21.2489.2489

Published: 2014

Journal Articles

BMP Pathway Alterations in Chronic Myelogenous Leukemia Lead to the Amplification of Primitive Progenitors Output in Chronic Phase

Franck E. Nicolini, MD, PhD, Bastien Laperoussaz, PhD student, Sandrine Jeanpierre, Tech., Karen Sagorny, PhD, Bastien Kaniewski, Tech., Stephane Morisset, Stat., Stéphanie Salesse, PhD, Thibault Voeltzel, PhD, Véronique maguer-Satta, PhD

Blood (2012) 120 (21): 1663.

DOI: https://doi.org/10.1182/blood.V120.21.1663.1663

Published: 2012

Journal Articles

Investigation of Urine/Plasma Biomarkers to Predict Tolerance and Graft-Versus-Host Disease Post Allogeneic Stem Cell Transplantation.

Christin Human, Sylvia Borchers, PhD, Michael Stadler, MD, Helmut Diedrich, Jürgen Krauter, MD, PhD, Christine Falk, Arnold Ganser, Eva M Mischak-Weissinger, MD

Blood (2012) 120 (21): 3049.

DOI: https://doi.org/10.1182/blood.V120.21.3049.3049

Published: 2012

Journal Articles

Modulation of Activin Signaling by RAP-011 (ActRIIA-IgG1) Improve Anemia, Increases Hemoglobin Levels and Corrects Ineffective Erythropoiesis in β-Thalassemia

Michael Dussiot, Thiago Maciel, PhD, Aurelie Fricot, Joel Veiga, Etienne Paubelle, Emmanuel Payen, Yves Beuzard, MD, Jean-Antoine Ribeil, MD, PhD, Jean-Benoît Arlet, MD, Genevieve Courtois, PhD, Tom O Daniel, MD, PhD, Rajesh Chopra, MD, PhD, Victoria Sung, Ph.D., Olivier Hermine, MD, PhD, Ivan Cruz Moura, PhD

Blood (2012) 120 (21): 247.

DOI: https://doi.org/10.1182/blood.V120.21.247.247

Published: 2012

Journal Articles

The Bone Morphogenetic Protein (BMP)-4 Is Involved in the Regulation of Human Megakaryocytic Differentiation during Thrombopoietin Signaling.

Franck E Nicolini, MD, PhD, Sandrine Jeanpierre, BSc, Bastien Kaniewski, BSc, Charles Dumontet, MD, PhD, Ruth Rimokh, PhD, Alain Puisieux, Pharmd, PhD, Véronique Maguer-Satta, PhD

Blood (2008) 112 (11): 1339.

DOI: https://doi.org/10.1182/blood.V112.11.1339.1339

Published: 2008

Journal Articles

BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling

Sandrine Jeanpierre, Franck Emmanuel Nicolini, Bastien Kaniewski, Charles Dumontet, Ruth Rimokh, Alain Puisieux, Véronique Maguer-Satta

Blood (2008) 112 (8): 3154–3163.

DOI: https://doi.org/10.1182/blood-2008-03-145326

Published: 2008

Includes: Supplemental data

NARROW

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial

Dysregulation of Follistatin Promotes Leukemogenesis in Acute Myeloid Leukemia

Transcriptomal Evidence for Dysregulation of Angiogenic Factors and Inflammatory Markers after Allogeneic Hematopoietic Cell Transplantation

Follistatin and Endoglin: Potential Biomarkers of Endothelial Damage and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0402

Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation

BMP Pathway Alterations in Chronic Myelogenous Leukemia Lead to the Amplification of Primitive Progenitors Output in Chronic Phase

Investigation of Urine/Plasma Biomarkers to Predict Tolerance and Graft-Versus-Host Disease Post Allogeneic Stem Cell Transplantation.

Modulation of Activin Signaling by RAP-011 (ActRIIA-IgG1) Improve Anemia, Increases Hemoglobin Levels and Corrects Ineffective Erythropoiesis in β-Thalassemia

The Bone Morphogenetic Protein (BMP)-4 Is Involved in the Regulation of Human Megakaryocytic Differentiation during Thrombopoietin Signaling.

BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only